Effect of financial incentives to physicians, patients, or both on lipid levels: A randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 314, Issue 18, 2015, Pages 1926-1935

  Asch, David A ^a,b   Troxel, Andrea B ^a   Stewart, Walter F ^c   Sequist, Thomas D ^d,e   Jones, James B ^c   Hirsch, Anne Marie G ^f   Hoffer, Karen ^a   Zhu, Jingsan ^a   Wang, Wenli ^a   Hodlofski, Amanda ^a   Frasch, Antonette B ^a   Weiner, Mark G ^g   Finnerty, Darra D ^a   Rosenthal, Meredith B ^h   Gangemi, Kelsey ^a   Volpp, Kevin G ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c SUTTER HEALTH   (United States)

^d PARTNERS HEALTHCARE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f GEISINGER HEALTH SYSTEM   (United States)

^g TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FINANCIAL INCENTIVE; FRAMINGHAM RISK SCORE; GENERAL PRACTITIONER; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MONEY; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REWARD; SINGLE BLIND PROCEDURE; UNITED STATES; ALGORITHM; BEHAVIORAL ECONOMICS; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; ECONOMICS; MIDDLE AGED; MOTIVATION; ORGANIZATION AND MANAGEMENT; PATIENT PARTICIPATION; PRIMARY HEALTH CARE; PSYCHOLOGY; REFERENCE VALUE; REIMBURSEMENT; STATISTICS AND NUMERICAL DATA; TIME;

ALGORITHMS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; ECONOMICS, BEHAVIORAL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MASSACHUSETTS; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATION; PATIENT PARTICIPATION; PENNSYLVANIA; PRIMARY HEALTH CARE; REFERENCE VALUES; REIMBURSEMENT, INCENTIVE; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 84946723459     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.14850     Document Type: Article

References (38)

1. Baigent C, Keech A, Kearney PM, et al; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospectivemeta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267-1278.
2. Austin PC, Mamdani MM, Juurlink DN, Alter DA, Tu JV.Missed opportunities in the secondary prevention ofmyocardial infarction: an assessment of the effects of statin underprescribing on mortality. Am Heart J. 2006;151(5):969-975.
3. Albert NM, Birtcher KK, Cannon CP, et al. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the GetWith the Guidelines database). Am J Cardiol. 2008;101(9):1242-1246.
4. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002; 288(4):462-467.
5. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality aftermyocardial infarction. Arch Intern Med. 2006; 166(17):1842-1847.
6. Hudson M, Richard H, Pilote L. Parabolas of medication use and discontinuation after myocardial infarction: are we closing the treatment gap? Pharmacoepidemiol Drug Saf. 2007;16(7):773-785.
7. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acutemyocardial infarction. JAMA. 2007;297(2): 177-186.
8. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: A retrospective cohort study. Can J Cardiol. 2005;21 (6):485-488.
9. Wei L,Wang J, Thompson P,Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients aftermyocardial infarction: A six year follow up study. Heart. 2002; 88(3):229-233.
10. Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance: from concept to practice. JAMA. 2005;294(14):1788-1793.
11. Petersen LA,Woodard LD, Urech T, Daw C, Sookanan S. Does pay-for-performance improve the quality of health care? Ann Intern Med. 2006; 145(4):265-272.
12. Houle SK, McAlister FA, Jackevicius CA, Chuck AW, Tsuyuki RT. Does performance-based remuneration for individual health care practitioners affect patient care? a systematic review. Ann Intern Med. 2012;157(12):889-899.
13. SuttonM, Nikolova S, Boaden R, Lester H, McDonald R, Roland M. Reduced mortality with hospital pay for performance in England. N Engl J Med. 2012;367(19):1821-1828.
14. Kristensen SR, Meacock R, Turner AJ, et al. Long-term effect of hospital pay for performance on mortality in England. N Engl J Med. 2014;371(6): 540-548.
15. Loewenstein G, Volpp KG, Asch DA. Incentives in health: different prescriptions for physicians and patients. JAMA. 2012;307(13):1375-1376.
16. Bosworth HB, Almirall D,Weiner BJ, et al. The implementation of a translational study involving a primary care based behavioral program to improve blood pressure control: The HTN-IMPROVE study protocol (01295). Implement Sci. 2010;5:54.
17. Asch DA, Volpp KG. On the way to health. LDI Issue Brief. 2012;17(9):1-4.
18. Rosenson RS. Statins: actions, side effects, and administration. UpToDate. http://www.uptodate .com/contents/statins-actions-side-effects-and-administration?source=machineLearning&search =statin+efficacy&selectedTitle=1-150 §ionRank=1&anchor=H3#H3. Accessed September 4, 2015.
19. Read D, Loewenstein G, RabinM. Choice bracketing. J Risk Uncertain. 1999;19(1):171-197. doi:10.1023/A:1007879411489.
20. Connolly T, Butler DU. Regret in economic and psychological theories of choice. J Behav Decis Making. 2006;19(2):139-154. doi:10.1002/bdm.510.
21. Chapman GB, Coups EJ. Emotions and preventive health behavior: worry, regret, and influenza vaccination. Health Psychol. 2006;25(1): 82-90.
22. Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: A randomized trial. JAMA. 2008;300(22):2631-2637.
23. Kimmel SE, Troxel AB, Loewenstein G, et al. Randomized trial of lottery-based incentives to improve warfarin adherence. Am Heart J. 2012;164 (2):268-274.
24. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979; 47(2):263-292.
25. Thaler RH, Tversky A, Kahneman DR, Schwartz A. The effect ofmyopia and loss aversion on risk taking: an experimental test. Q J Econ. 1997; 112(2):647-661.
26. Nauck M,Warnick GR, Rifai N.Methods for measurement of LDL-cholesterol: A critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem. 2002;48(2):236-254.
27. Diggle PJ, Heagerty P, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. 2nd ed. New York, NY: Oxford University Press; 2002.
28. Rubin D. Multiple Imputation for Nonresponse in Surveys. New York, NY: J. Wiley & Sons; 1987.
29. Luczak K, Piestrzeniewicz K, Maciejewski M, et al. Long-lasting durability of Carpentier-Edwards pericardial bovine bioprosthesis in mitral position: A case report of unfavourable post redo valve surgery course. Kardiol Pol. 2010;68(7):806-808.
30. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6(2):65-70.
31. Volpp KG, Loewenstein G, Troxel AB, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008;8:272.
32. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-3035.
33. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4): 772-779.
34. Grady KE, Lemkau JP, Lee NR, Caddell C. Enhancing mammography referral in primary care. Prev Med. 1997;26(6):791-800.
35. Loewenstein G, Asch DA, Volpp KG. Behavioral economics holds potential to deliver better results for patients, insurers, and employers. Health Aff (Millwood). 2013;32(7):1244-1250.
36. Petersen LA, Simpson K, Pietz K, et al. Effects of individual physician-level and practice-level financial incentives on hypertension care: A randomized trial. JAMA. 2013;310(10):1042-1050.
37. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-3421.
38. Stone NJ, Robinson JG, Lichtenstein AH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J AmColl Cardiol. 2014;63(25 pt B):2889-2934.